Target intelligence / Profile preview

Lipid free radical (L•)

Target
L•
Molecular classification
Reactive oxygen species (ROS), Reactive lipid species (RLS), Free radical
01

Overview

Lipid free radicals are highly reactive chemical species, such as lipid peroxyl (LOO•) and alkoxyl (LO•) radicals, produced during the oxidative degradation of lipids, particularly polyunsaturated fatty acids (Ayala et al., 2014, Oxidative Medicine and Cellular Longevity). These radicals drive the process of lipid peroxidation, a self-propagating chain reaction that disrupts cellular membrane integrity and generates toxic secondary products like malondialdehyde and 4-hydroxynonenal (Gaschler & Stockwell, 2017, Nature Chemical Biology). In a pathological context, the accumulation of lipid radicals is a hallmark of ferroptosis, an iron-dependent form of regulated cell death linked to neurodegeneration, cancer, and ischemia-reperfusion injury (Dixon et al., 2012, Cell). Therapeutic strategies target these radicals through chain-breaking antioxidants, such as alpha-tocopherol (Vitamin E), or specialized scavengers like edaravone, which is used clinically to treat amyotrophic lateral sclerosis (Yoshino & Itoh, 2013, CNS Neuroscience & Therapeutics). By neutralizing lipid radicals, these agents prevent the cascade of oxidative damage and protect cells from ferroptotic death (Conrad et al., 2018, Nature Chemical Biology).

Other names
Lipid radicalLipid peroxyl radical (LOO•)Lipid alkoxyl radical (LO•)Polyunsaturated fatty acid radicalLipid alkyl radical (L•)
02

Mechanism of action

Chain-breaking antioxidant activity that terminates the propagation of lipid peroxidation by donating a hydrogen atom to lipid peroxyl radicals, thereby forming a stable non-radical product.

03

Biological functions

Lipid peroxidationFerroptosisCell signalingMembrane degradationOxidative stress propagation
04

Disease associations

Amyotrophic lateral sclerosis (ALS)AtherosclerosisAlzheimer diseaseParkinson diseaseIschemia-reperfusion injuryCancer
05

Safety considerations

Potential pro-oxidant effects at high concentrationsInterference with essential physiological redox signalingPoor clinical translation of non-specific antioxidantsBioavailability and membrane penetration challenges
06

Interacting drugs

Alpha-tocopherol (Vitamin E)

6 more in the full profile.

07

Biomarkers

Malondialdehyde (MDA)4-Hydroxynonenal (4-HNE)8-iso-Prostaglandin F2alpha (8-iso-PGF2α)Lipid hydroperoxides (LOOH)

Beyond the preview

Go deeper on Lipid free radical (L•).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lipid free radical (L•).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call